Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-26 of 26
1-26 of 26
Filter
Joseph Tucker
President & CEO at MagicMed Industries
cannabis event 2021, cannabis stocks and options, antidepressant, attention deficit hyperactivity disorder, benzinga cannabis , benzinga news, bioavailability, biotechnology, cannabinoid, cannabis conference 2021, cannabis earnings, cannabis entrepreneurs , cannabis hedge funds, cannabis investments, cannabis investor presentation , chemical substance, chemistry, clinical trial, conversation, dopamine, drug, drug development, drug discovery, drug liberalization, enzyme, experience, first-mover advantage, hallucination, health care, health professional, hemp, highest quality cannabis, hope, investor, library, lysergic acid diethylamide, major depressive disorder, marijuana, mdma, medical cannabis, medication, mental disorder, mental health, mescaline, pharmaceutical industry, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychedelics, psychologist, psychology, psychotherapy, receptor antagonist, science, serotonin, stock prices, synthetic biology, veteran
Graham Simmonds
CEO at Aion Therapeutic
aion therapeutics, benzinga cannabis , benzinga cannabis capital conference 2021, botany, cancer, cannabidiol, cannabis entrepreneurs , drug, drug discovery, experience, expert, graham simmonds, health, infrastructure, intellectual property, invention, investment, investor, jamaica, license, medical cannabis, medical mushrooms, medication, mental health, nutraceutical, patent, property, psilocybin, psychedelic drug, research, science, tetrahydrocannabinol
Andrew Corrieri
Consultant and founder at Pharmaconsulta Lt
addiction, black market, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, consciousness, dose (biochemistry), drug, drug overdose, education, federal government of the united states, good manufacturing practice, heroin, hiv/aids in the united states, inspection, joe biden, laboratory, logistics, medical cannabis, medication, morphine, narcotic, opiate, opioid, opioid use disorder, opium, palliative care, pharmaceutical industry, pharmacovigilance, pharmacy, physician, postmarketing surveillance, prescription drug, prohibition of drugs, psychedelic drug, quality management system, regulation of therapeutic goods, regulatory affairs, substance dependence, target market, warehouse
Stephen Oliver
Co-Founder at The Canna Consultants
addiction, adverse effect, black market, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, consciousness, controlled substance, criminalization, dose (biochemistry), drug, drug overdose, drug policy, european union, explanation, federal government of the united states, food, hiv/aids in the united states, joe biden, jurisdiction, law, medical cannabis, medication, mining, narcotic, netherlands, novel food, opioid, opioid use disorder, pharmaceutical industry, prescription drug, prohibition of drugs, psychedelic drug, regulation of therapeutic goods, smuggling, substance dependence, switzerland, tetrahydrocannabinol, u.s. state, war on drugs
Henri Sant-Cassia
Co-Founding Partner at The Conscious Fund
addiction, antidepressant, black market, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, competition, consciousness, dose (biochemistry), drug, drug overdose, epilepsy, epileptic seizure, esketamine, federal government of the united states, hiv/aids in the united states, joe biden, johnson & johnson, major depressive disorder, medical cannabis, medication, mental health, opioid, opioid use disorder, pain management, pharmaceutical industry, pharmacy, post-traumatic stress disorder, prescription drug, prohibition of drugs, psychedelic drug, psychiatry, psychosis, regulation of therapeutic goods, substance dependence, synthetic cannabinoids, telehealth, thailand, treatment-resistant depression
Albert Tió
President at Federation of Self-regulated Cannabis Associations of Catalonia (Fedcac) at FEDCAC
addiction, awareness, black market, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), celebrity, change.org, clinical trial, cold medicine, consciousness, constitution of spain, dose (biochemistry), drug, drug overdose, european union, evidence-based medicine, federal government of the united states, federation, hiv/aids in the united states, joe biden, jurisdiction, law, market (economics), medical cannabis, medication, medicine, mental disorder, mental health, multidisciplinary association for psychedelic studies, national labor relations board, nevis, news, nonprofit organization, opioid, opioid use disorder, opium, over-the-counter drug, pharmaceutical industry, pharmacy, physician, prescription drug, profit (economics), prohibition of drugs, psilocybin, psychedelic drug, regulation of therapeutic goods, regulatory compliance, science, smoking, spain, substance dependence, supreme court of the united kingdom, supreme court of the united states, tetrahydrocannabinol, tobacco, traditional chinese medicine, wealth
Dustin Robinson
Founding Partner at Mr. Cannabis Law
advertising, angel investor, bank, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), caregiver, clinical trial, commerce clause, dividend, dividend tax, doctor–patient relationship, dose (biochemistry), dronabinol, drug, economics, employment, evidence-based medicine, expense, flow-through entity, food and drug administration, franchising, innovation, interest, internal revenue service, investment, joe biden, jurisdiction, legality of cannabis, limited liability company, limited liability partnership, loan, major depressive disorder, market (economics), mdma, medical cannabis, medication, medicine, mergers and acquisitions, mergers, and acquisitions, multidisciplinary association for psychedelic studies, nevis, opioid, opium, over-the-counter drug, ownership, pain management, partnership, pharmacy, physician, prescription drug, price, psilocybin, psychedelic drug, rate of return, regulatory compliance, seed money, social stigma, supply chain, tax, tax rate, tetrahydrocannabinol, traditional chinese medicine, unemployment, valuation (finance)
Cheryl Shuman
Chief Executive Officer at Beverly Hills Cannabis Club
addiction, bill maher, black market, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cash crop, cbs, clinical trial, cold medicine, coming out, consciousness, dose (biochemistry), drug, drug overdose, federal government of the united states, fox business, hiv/aids in the united states, joe biden, joe rogan, medical cannabis, medication, milk, nbc, netflix, nursing, opioid, opioid use disorder, personal branding, pharmaceutical industry, prescription drug, product placement, prohibition of drugs, psychedelic drug, regulation of therapeutic goods, ricki lake, sanjay gupta, social media, substance dependence, television, the view (talk show), tommy chong, toy, vlog, wheat, whoopi goldberg, willie nelson
Priscilla Agoncillo
Co-Founder at Original Breeders League
agriculture, anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, clinical trial, consciousness, cotton, crispr, crispr gene editing, democratic party (united states), disease, dispensary, dna, dna sequencing, dominance (genetics), dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, ethnobotany, food and drug administration, free market, gene, gene mapping, genetic engineering, genetically modified organism, genetics, genome, gerrymandering, good manufacturing practice, hair loss, hashish, health, health care, hemp, human genome, landrace, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, micropropagation, mood stabilizer, neuroplasticity, neurotransmitter, neutron, organism, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, plant tissue culture, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, science, selective serotonin reuptake inhibitor, sense, sequencing, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression, whole genome sequencing
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Salimeh Tabrizi
Co-Founder at Canadian Psychedelic Association
alison draisin, alternative medicine, android (operating system), antipsychotic, awareness, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis and psychedelics, cannabis strain, consciousness, dr. dominic corva, dr. jim fadiman, dronabinol, entheogens, entropy, eric boone, forgiveness, hinduism, hypnosis, indian reservation, ios, mdma, medicine, meditation, mental disorder, mind, mobile app, monte levine, native american church, native americans in the united states, palliative care, physician, privacy, prohibition of drugs, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, public spiritual health, relaxation (psychology), religion, religious experience, salimeh tabrizi, seattle hempfest 2020, seattle hempfest 2020 online, second law of thermodynamics, self, self-actualization, serotonin, shiva, spirituality, substance theory, sunil aggarwal, support for your mental health, terminal illness, tetrahydrocannabinol, yoga
James Fadiman
Senior Research Fellow at Sofia University
alison draisin, android (operating system), antipsychotic, cannabidiol, cannabinoid, cannabis (drug), cannabis and psychedelics, cannabis strain, dr. jim fadiman, dronabinol, entropy, eric boone, forgiveness, hypnosis, ios, mdma, meditation, mind, mobile app, privacy, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, religious experience, salimeh tabrizi, seattle hempfest 2020 online, second law of thermodynamics, serotonin, support for your mental health, tetrahydrocannabinol
Alison Draisin
Psychologist at AIMS Institute
alison draisin, android (operating system), antipsychotic, cannabidiol, cannabinoid, cannabis (drug), cannabis and psychedelics, cannabis strain, dr. jim fadiman, dronabinol, entropy, eric boone, forgiveness, hypnosis, ios, mdma, meditation, mind, mobile app, privacy, psychedelic drug, psychedelic therapy, psychiatry, psychological trauma, psychotherapy, religious experience, salimeh tabrizi, seattle hempfest 2020 online, second law of thermodynamics, serotonin, support for your mental health, tetrahydrocannabinol
Thomas Howard
Co Host at Cannabis Legalization News
anti-inflammatory, antidepressant, anxiolytic, bank, bodyguard, brick and mortar, cannabidiol, cannabinoid, cannabis, cannabis (drug), credit card, crime, democratic party (united states), electronic cigarette, entourage effect, fence (criminal), financial crime, food and drug administration, gerrymandering, hsbc, jpmorgan chase, major depressive disorder, mastercard, mechanism of action, medical cannabis, medication, money laundering, neuroplasticity, neurotransmitter, paypal, pharmacology, post-traumatic stress disorder, price, psilocybin, psilocybin mushroom, psychedelic drug, sense, serotonin, suspicious activity report, swing state, tetrahydrocannabinol, underwriting, united states department of agriculture, united states postal service, visa inc.
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
David Feldman
Attorney at Skip Intro Advisors
alternative medicine, anxiety, balance sheet, bank, brand, cannabis capital conference, cannabis community, cannabis consulting, cannabis funds, cannabis industry, cannabis investor presentation , cannabis market growth, cannabis sales, capital market, clinical trial, competition (economics), consultant, cost of capital, debt, drug, drug liberalization, drug overdose, earnings before interest, taxes, depreciation and amortization, equity (finance), finance, food and drug administration, goal, health, ibogaine, innovation, investment, investment banking, leadership, leaseback, lysergic acid diethylamide, major depressive disorder, market (economics), medication, mental disorder, motivation, n,n-dimethyltryptamine, opioid, perception, pharmacology, pricing, private equity, psilocybin, psychedelic drug, psychedelic science, psychiatry, psychology, psychotherapy, social stigma, stock dilution, substance use disorder, united states congress
Timothy Ko
CEO at Entheon Biomedical
alternative medicine, anxiety, clinical trial, drug, drug liberalization, drug overdose, food and drug administration, health, ibogaine, lysergic acid diethylamide, major depressive disorder, medication, mental disorder, motivation, n,n-dimethyltryptamine, opioid, perception, pharmacology, psilocybin, psychedelic drug, psychiatry, psychology, psychotherapy, social stigma, substance use disorder
Jourdan Woltz
Owner at JADE Healing Co CBD
antidepressant, autism, belief, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, dose (biochemistry), dronabinol, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, health care, hexane, high-performance liquid chromatography, isopropyl alcohol, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, solution, substance dependence, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, treatment-resistant depression, water
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Annie Epley
Director of Operations at From Soil to Soul, LLC
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Trey Tijerina
Owner at WhyPayTrey
advertising, antidepressant, audience measurement, audit, autism, avatar (computing), belief, blog, brand, brand awareness, cannabidiol, cannabinoid, cannabis, carbon dioxide, credibility, digital marketing, dose (biochemistry), dronabinol, facebook, false advertising, game balance, good manufacturing practice, google, google search, hashtag, health care, hemp, inbound marketing, instagram, internet, linkedin, major depressive disorder, management of depression, massage, mdma, medical cannabis, medicine, mental health, mood stabilizer, news, newspaper, pharmaceutical industry, pharmacy, podcast, product sample, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, publicist, publishing, radio advertisement, research, search engine optimization, selective serotonin reuptake inhibitor, small business, social media, social media marketing, social stigma, substance dependence, symbol, target market, testimonial, treatment-resistant depression, twitter, vlog, youtube
JR Rahn
Founder & Co-CEO at MindMed
2019, addiction, alcoholism, alternative, biohacking, biotech, biotechnology, blinded experiment, business, cambridge house, cannabis (drug), cannabis act, capital, cognitive behavioral therapy, company, compass pathways, conference, consciousness, criminalization, dennis mckena, downtown eastside, drug development, drug discovery, eli lilly and company, entrepreneur, event, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, homelessness, ibogaine, investing, johns hopkins university, jr rahn, ketamine, lars wilde, lysergic acid diethylamide, magic mushrooms, major depressive disorder, market, matthew johnson, mdma, medication, medicine, mental health, mentorship, micro dosing, mind, mindmed, money, motivation, motivational interviewing, mushrooms, opioid, opioid epidemic in the united states, panel, pharmaceutical industry, phases of clinical research, placebo, psilocybin, psilocybin mushroom, psychedelic drug, psychedelics, psychotherapy, public, research, science, silicon valley, social control, spiritual, startup accelerator, startup company, stock, stocks, substance abuse, tech, the doors of perception, therapy, tim ferriss, time, treatment, treatment-resistant depression, varenicline, xf, y combinator
Charles Grob
Directior, Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
Robert Jesse
Researcher, non-profit organizer at The Johns Hopkins University
anxiety, autism spectrum, clinical trial, disease, food and drug administration, hallucinogen, major depressive disorder, mdma, mental disorder, mental health, michael pollan, multidisciplinary association for psychedelic studies, phases of clinical research, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, startups, substance dependence, technology, the doors of perception, therapy, treatment of mental disorders, venture capital
Joe Green
Collaborative & Co-Founder and Chairman at Treehouse Co-Living
affordable housing, airbnb, anxiety, autism spectrum, bank, beverly hills, california, california, clinical trial, community, construction, disease, education, food and drug administration, hallucinogen, housing, lawn, lawsuit, loan, loneliness, los angeles, major depressive disorder, mdma, mental disorder, mental health, michael pollan, money, multidisciplinary association for psychedelic studies, nimby, phases of clinical research, post-traumatic stress disorder, poverty, psilocybin, psilocybin mushroom, psychedelic drug, psychedelic therapy, psychiatry, psychopharmacology, psychotherapy, santa monica, california, science, scott wiener, secondary suite, startups, substance dependence, suburb, technology, the doors of perception, therapy, trade union, treatment of mental disorders, urban sprawl, venture capital, wage, walkability, watts, los angeles, zoning
1
1-26 of 26